These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11278606)

  • 1. Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen.
    Iida J; Pei D; Kang T; Simpson MA; Herlyn M; Furcht LT; McCarthy JB
    J Biol Chem; 2001 Jun; 276(22):18786-94. PubMed ID: 11278606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A).
    Iida J; Wilhelmson KL; Ng J; Lee P; Morrison C; Tam E; Overall CM; McCarthy JB
    Biochem J; 2007 May; 403(3):553-63. PubMed ID: 17217338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion.
    Faassen AE; Schrager JA; Klein DJ; Oegema TR; Couchman JR; McCarthy JB
    J Cell Biol; 1992 Jan; 116(2):521-31. PubMed ID: 1730766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-type-3 matrix metalloproteinase (MT3-MMP) functions as a matrix composition-dependent effector of melanoma cell invasion.
    Tatti O; Arjama M; Ranki A; Weiss SJ; Keski-Oja J; Lehti K
    PLoS One; 2011; 6(12):e28325. PubMed ID: 22164270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-beta-stimulated mouse melanoma cell motility and invasive behavior on type I collagen.
    Faassen AE; Mooradian DL; Tranquillo RT; Dickinson RB; Letourneau PC; Oegema TR; McCarthy JB
    J Cell Sci; 1993 Jun; 105 ( Pt 2)():501-11. PubMed ID: 7691842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
    Nakada M; Miyamori H; Yamashita J; Sato H
    Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of pro-matrix metalloproteinase-9/proteoglycan heteromer with gelatin and collagen.
    Malla N; Berg E; Uhlin-Hansen L; Winberg JO
    J Biol Chem; 2008 May; 283(20):13652-65. PubMed ID: 18359769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-type matrix metalloproteinase-1 and -3 activity in primate smooth muscle cells.
    Shofuda KI; Hasenstab D; Kenagy RD; Shofuda T; Li ZY; Lieber A; Clowes AW
    FASEB J; 2001 Sep; 15(11):2010-2. PubMed ID: 11511522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines.
    Kurschat P; Zigrino P; Nischt R; Breitkopf K; Steurer P; Klein CE; Krieg T; Mauch C
    J Biol Chem; 1999 Jul; 274(30):21056-62. PubMed ID: 10409657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes.
    Knutson JR; Iida J; Fields GB; McCarthy JB
    Mol Biol Cell; 1996 Mar; 7(3):383-96. PubMed ID: 8868467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas.
    Eisenmann KM; McCarthy JB; Simpson MA; Keely PJ; Guan JL; Tachibana K; Lim L; Manser E; Furcht LT; Iida J
    Nat Cell Biol; 1999 Dec; 1(8):507-13. PubMed ID: 10587647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1.
    Durko M; Navab R; Shibata HR; Brodt P
    Biochim Biophys Acta; 1997 May; 1356(3):271-80. PubMed ID: 9194570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth.
    Iida J; Wilhelmson KL; Price MA; Wilson CM; Pei D; Furcht LT; McCarthy JB
    J Invest Dermatol; 2004 Jan; 122(1):167-76. PubMed ID: 14962105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
    Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R
    J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) Is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen.
    Wang P; Nie J; Pei D
    J Biol Chem; 2004 Dec; 279(49):51148-55. PubMed ID: 15381707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1.
    Gao G; Plaas A; Thompson VP; Jin S; Zuo F; Sandy JD
    J Biol Chem; 2004 Mar; 279(11):10042-51. PubMed ID: 14701864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes.
    Nakada M; Yamada A; Takino T; Miyamori H; Takahashi T; Yamashita J; Sato H
    Cancer Res; 2001 Dec; 61(24):8896-902. PubMed ID: 11751414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells.
    Ohnishi Y; Tajima S; Ishibashi A
    Eur J Dermatol; 2001; 11(5):420-3. PubMed ID: 11525948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA.
    Matsumoto S; Katoh M; Saito S; Watanabe T; Masuho Y
    Biochim Biophys Acta; 1997 Nov; 1354(2):159-70. PubMed ID: 9396633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of MT-MMPs and MMP-2 in pancreatic cancer progression.
    Ellenrieder V; Alber B; Lacher U; Hendler SF; Menke A; Boeck W; Wagner M; Wilda M; Friess H; Büchler M; Adler G; Gress TM
    Int J Cancer; 2000 Jan; 85(1):14-20. PubMed ID: 10585576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.